FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience.
Chllamma, M Cook, Natalie Dhani, N Giby, K Dodd, A Wang, L Hedley, D Moore, M Knox, J
Chllamma, M
Cook, Natalie
Dhani, N
Giby, K
Dodd, A
Wang, L
Hedley, D
Moore, M
Knox, J
Citations
Altmetric:
Abstract
FOLFIRINOX has been shown to significantly increase both overall survival (OS) and progression-free survival (PFS) in metastatic pancreas cancer. There is limited data regarding the treatment of locally advanced pancreatic cancer. We present a retrospective study of patients with both locally advanced and metastatic pancreas cancer using FOLFIRINOX as first-line therapy in our centre.
Description
Date
2016-09-06
Publisher
Collections
Keywords
Type
Article
Citation
FOLFIRINOX for advanced pancreatic cancer: the Princess Margaret Cancer Centre experience. 2016, 115 (6):649-54 Br J Cancer